Navigation Links
Palomar Medical Reports Financial Results for Second Quarter 2009
Date:7/30/2009

ct of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products and additional applications, the results of litigation, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, factors affecting the Company's future income and resulting ability to utilize its NOLs, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2008 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    Contact:  Kayla Castle
              Investor Relations Manager
              Palomar Medical Technologies, Inc.
              781-993-2411
              ir@palomarmedical.com

    Palomar Financial Summary:
    Consolidated Statements of Operations (Unaudited)


                                 Three Months Ended          Six Months Ended
                                     June 30,                   June 30,
                               2009          2008         2009         2008
                               ----          ----         ----         ----
    Revenues:
     Product revenues      $12,120,856  $19,206,511  $23,594,410  $36,895,304
     Royalty revenues        1,274,593    2,269,561    2,768,017    5,516,584

'/>"/>
SOURCE Palomar Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
3. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
4. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
5. Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. Palomar Medical Reports Financial Results for Third Quarter 2008
8. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
9. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
10. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
11. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... On more positive note, CDC sees few signs of tro...AY, Nov. 25 (HealthDay News) -- The ongoing H1N1 s... dangerous pneumonias among younger patients, a U....eing an increase in serious pneumococcal infection... of the National Center for Immunization and Respi...
(Date:11/25/2009)... , A drug used to treat colorectal cancer also ca...nsidered first-line therapy for the disease, resea...ort this week. , Mntrier,s disease causes thicken...nausea and vomiting, as well as anemia and swellin...ents are at increased risk for gastric cancer. Pre...
(Date:11/25/2009)... , Initiative expands to ...ing for students, teachers, and healthcare profess... Pleasanton, CA (PRWEB) November 25, 2009 -- ...o and social networking solutions that support 21...announced today that its Fire and Ice initiative...
(Date:11/25/2009)... ,, SALTLAKECITY,Nov.25/PRNewswire/--dazzles...ce,LLC www.optimalhealthscience.com havefileda67-p...dsAKAazoogle.com,Inc.,JesseWillms,FarendServicesLi...ledwiththeUnitedStatesDistrictCourtfortheDistricto...eitingofdazzlesmile(TM)brandedteethwhiteningproduc...
(Date:11/25/2009)... , This release is available in French and Sp...ty of Granada have provided an early diagnosis of...y, such as age-related macular degeneration and ke... that, nevertheless, had never before been used fo... studied the image quality in subjects affected by...
Breaking Medicine News(10 mins):Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Achieve early diagnosis of ocular pathologies such as keratitis and macular degeneration 2
...sights might produce treatments to kill off cancer...News) -- New information about a process called un... fight against heart disease, cancer, stroke and o...planned cell death caused by outside factors, such...
...NILWORTH, N.J., Sept. 21 Schering-Plough,Corporat...es and earnings,results for the 2007 third quarter...t day, Schering-Plough will conduct a conference,c...ence call. To listen live to the call, dial 1-877...
...STIN, Texas, Sept. 21 A sellout crowd will honor,...ine, Monday at the 5th,Annual Speaker,s Golf Tourn...eded the amount of money raised by last year,s tou...his important event, proceeds from the tournament ...
...partisan, bicameral coalition ready to move on ful...ept. 21 A bipartisan coalition,of Senate and Hous...,reauthorize the Children,s Health Insurance Progr... private,insurance. The $35 billion agreement stru...
...e earlier kids abuse alcohol, the more likely it i...t. 21 (HealthDay News) -- Parents sometimes look u...ut new research suggests it has a darker side, one...re more likely to be injured, to be in motor vehic...
... Research conducted at the University of Californi...w light on the structure and function of one of th...ase A (PKA), an enzyme which plays an essential ro...olved the structure of the large PKA complex, reve...
Other Medicine News:Health News:Clues to Cell Death Could Fight Disease 2Health News:2007 Speaker's Golf Tournament Sets 5-Year Fundraising Record 2Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 2Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 3Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 4Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 5Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 6Health News:Senate, House Announce Agreement to Renew, Improve Children's Health Insurance Program Now 7Health News:Teenage Drinking Can Spell Lasting Trouble 2Health News:Teenage Drinking Can Spell Lasting Trouble 3Health News:UCSD study reveals the regulatory mechanism of key enzyme 2
(Date:11/25/2009)...tCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevic...ruptivesurgicaltreatmentsforthespine,announcedtoda...2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwill...ompany,sproductsandwillincludecommentsfrommanageme...-innumbersare1-877-407-4018fordomesticcallersand1-...
(Date:11/25/2009)...5/PRNewswire-FirstCall/--HeartWareInternational,In...ideroflessinvasive,miniaturizedcirculatorysupportt...artfailure,todayannouncedthatitisscheduledtomakean...lthCareConferenceat8:00amESTonWednesday,December2,...el,December1-2. ,, AlivewebcastoftheCompany,spr...
(Date:11/24/2009)...FirstCall/--QuestDiagnosticsIncorporated(NYSE: DGX...formationandservices,announcedthatitisscheduledtos...einNewYorkCity.ThepresentationisscheduledforWednes...ingtheconference,thecompanywillreaffirmits2009guid...etoexceed18%ofrevenues,anddilutedearningspersharef...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2SC Johnson Makes Commitment to Clinton Global Initiative 61192 1SC Johnson Makes Commitment to Clinton Global Initiative 61192 2SC Johnson Makes Commitment to Clinton Global Initiative 61192 3Memphis Mayor Endorses National Bipolar Foundation 61190 1Memphis Mayor Endorses National Bipolar Foundation 61190 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 1Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 2Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 3Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 4Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 5Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 6Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 7Oncothyreon reports third quarter 2009 financial results 26amp 3B provides product pipeline update 14800 8
...System Selected as Exclusive Cryoablation ..., Calif., Oct. 28 The American College of,Surgeon...ational Cancer,Institute (NCI) funded clinical tri...ss of Cryoablation Therapy in the Treatment of Inv...(TM) Treatment System from Sanarus,Medical as the ...
...esearch Group Limited,the international pharmaceut...nical Practice Journal (GCPj) Award for the "Clini...e 2 Chronic Myeloid Leukemia team. This award,is o...ebrates, and rewards,corporate and individual exce...rch Team of the Year" award honors the achievement...
Other Medicine Technology:NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation 2NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation 3Premier Research Honored as 'Clinical Research Team of the Year' at 2008 GCPj Awards 2
Fiber Optic Otoscope
Earscope Model 1205
Pocket Otoscope
Ri-star® Fiber-optic Otoscope
Medicine Products: